Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • General Statistics
    • Editorial Board
    • Editors
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Acknowledgment of Reviewers
    • Clinical Implications
    • Clinical-Pathological Conferences
    • Controversies in Hypertension
    • Editors' Picks
    • Guidelines Debate
    • Meeting Abstracts
    • Recent Advances in Hypertension
    • SPRINT Trial: the Conversation Continues
  • Resources
    • Instructions to Reviewers
    • Instructions for Authors
    • →Article Types
    • → Submission Guidelines
      • Research Guidelines
        • Minimum Information About Microarray Data Experiments (MIAME)
      • Abstract
      • Acknowledgments
      • Clinical Implications (Only by invitation)
      • Conflict(s) of Interest/Disclosure(s) Statement
      • Figure Legends
      • Figures
      • Novelty and Significance: 1) What Is New, 2) What Is Relevant?
      • References
      • Sources of Funding
      • Tables
      • Text
      • Title Page
      • Online/Data Supplement
    • →Tips for Easier Manuscript Submission
    • → General Instructions for Revised Manuscripts
      • Change of Authorship Form
    • → Costs to Authors
    • → Open Access, Repositories, & Author Rights Q&A
    • Permissions to Reprint Figures and Tables
    • Journal Policies
    • Scientific Councils
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Hypertension

  • My alerts
  • Sign In
  • Join

  • Facebook
  • Twitter
  • Home
  • About this Journal
    • General Statistics
    • Editorial Board
    • Editors
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Acknowledgment of Reviewers
    • Clinical Implications
    • Clinical-Pathological Conferences
    • Controversies in Hypertension
    • Editors' Picks
    • Guidelines Debate
    • Meeting Abstracts
    • Recent Advances in Hypertension
    • SPRINT Trial: the Conversation Continues
  • Resources
    • Instructions to Reviewers
    • Instructions for Authors
    • →Article Types
    • → Submission Guidelines
    • →Tips for Easier Manuscript Submission
    • → General Instructions for Revised Manuscripts
    • → Costs to Authors
    • → Open Access, Repositories, & Author Rights Q&A
    • Permissions to Reprint Figures and Tables
    • Journal Policies
    • Scientific Councils
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Original Article

Effective Arterial Elastance Is Insensitive to Pulsatile Arterial LoadNovelty and Significance

Julio A. Chirinos, Ernst R. Rietzschel, Prithvi Shiva-Kumar, Marc L. De Buyzere, Payman Zamani, Tom Claessens, Salvatore Geraci, Prasad Konda, Dirk De Bacquer, Scott R. Akers, Thierry C. Gillebert, Patrick Segers
Download PDF
https://doi.org/10.1161/HYPERTENSIONAHA.114.03696
Hypertension. 2014;64:1022-1031
Originally published July 28, 2014
Julio A. Chirinos
From the Department of Medicine, Perelman School of Medicine and Hospital of the University of Pennsylvania, Philadelphia (J.A.C., P.Z.); Department of Medicine, Philadelphia VA Medical Center, PA (J.A.C., P.S.-K., S.R.A., S.G.); Department of Cardiovascular Diseases, Ghent University Hospital, Ghent, Belgium (E.R.R., M.L.D.B., D.D.B.); and Department of Public Health (E.R.R.), Department of Industrial Technology and Construction (T.C.), and Institute Biomedical Technology, iMinds Future Health Department (T.C., P.S.), Ghent University, Ghent, Belgium.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ernst R. Rietzschel
From the Department of Medicine, Perelman School of Medicine and Hospital of the University of Pennsylvania, Philadelphia (J.A.C., P.Z.); Department of Medicine, Philadelphia VA Medical Center, PA (J.A.C., P.S.-K., S.R.A., S.G.); Department of Cardiovascular Diseases, Ghent University Hospital, Ghent, Belgium (E.R.R., M.L.D.B., D.D.B.); and Department of Public Health (E.R.R.), Department of Industrial Technology and Construction (T.C.), and Institute Biomedical Technology, iMinds Future Health Department (T.C., P.S.), Ghent University, Ghent, Belgium.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Prithvi Shiva-Kumar
From the Department of Medicine, Perelman School of Medicine and Hospital of the University of Pennsylvania, Philadelphia (J.A.C., P.Z.); Department of Medicine, Philadelphia VA Medical Center, PA (J.A.C., P.S.-K., S.R.A., S.G.); Department of Cardiovascular Diseases, Ghent University Hospital, Ghent, Belgium (E.R.R., M.L.D.B., D.D.B.); and Department of Public Health (E.R.R.), Department of Industrial Technology and Construction (T.C.), and Institute Biomedical Technology, iMinds Future Health Department (T.C., P.S.), Ghent University, Ghent, Belgium.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc L. De Buyzere
From the Department of Medicine, Perelman School of Medicine and Hospital of the University of Pennsylvania, Philadelphia (J.A.C., P.Z.); Department of Medicine, Philadelphia VA Medical Center, PA (J.A.C., P.S.-K., S.R.A., S.G.); Department of Cardiovascular Diseases, Ghent University Hospital, Ghent, Belgium (E.R.R., M.L.D.B., D.D.B.); and Department of Public Health (E.R.R.), Department of Industrial Technology and Construction (T.C.), and Institute Biomedical Technology, iMinds Future Health Department (T.C., P.S.), Ghent University, Ghent, Belgium.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Payman Zamani
From the Department of Medicine, Perelman School of Medicine and Hospital of the University of Pennsylvania, Philadelphia (J.A.C., P.Z.); Department of Medicine, Philadelphia VA Medical Center, PA (J.A.C., P.S.-K., S.R.A., S.G.); Department of Cardiovascular Diseases, Ghent University Hospital, Ghent, Belgium (E.R.R., M.L.D.B., D.D.B.); and Department of Public Health (E.R.R.), Department of Industrial Technology and Construction (T.C.), and Institute Biomedical Technology, iMinds Future Health Department (T.C., P.S.), Ghent University, Ghent, Belgium.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tom Claessens
From the Department of Medicine, Perelman School of Medicine and Hospital of the University of Pennsylvania, Philadelphia (J.A.C., P.Z.); Department of Medicine, Philadelphia VA Medical Center, PA (J.A.C., P.S.-K., S.R.A., S.G.); Department of Cardiovascular Diseases, Ghent University Hospital, Ghent, Belgium (E.R.R., M.L.D.B., D.D.B.); and Department of Public Health (E.R.R.), Department of Industrial Technology and Construction (T.C.), and Institute Biomedical Technology, iMinds Future Health Department (T.C., P.S.), Ghent University, Ghent, Belgium.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Salvatore Geraci
From the Department of Medicine, Perelman School of Medicine and Hospital of the University of Pennsylvania, Philadelphia (J.A.C., P.Z.); Department of Medicine, Philadelphia VA Medical Center, PA (J.A.C., P.S.-K., S.R.A., S.G.); Department of Cardiovascular Diseases, Ghent University Hospital, Ghent, Belgium (E.R.R., M.L.D.B., D.D.B.); and Department of Public Health (E.R.R.), Department of Industrial Technology and Construction (T.C.), and Institute Biomedical Technology, iMinds Future Health Department (T.C., P.S.), Ghent University, Ghent, Belgium.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Prasad Konda
From the Department of Medicine, Perelman School of Medicine and Hospital of the University of Pennsylvania, Philadelphia (J.A.C., P.Z.); Department of Medicine, Philadelphia VA Medical Center, PA (J.A.C., P.S.-K., S.R.A., S.G.); Department of Cardiovascular Diseases, Ghent University Hospital, Ghent, Belgium (E.R.R., M.L.D.B., D.D.B.); and Department of Public Health (E.R.R.), Department of Industrial Technology and Construction (T.C.), and Institute Biomedical Technology, iMinds Future Health Department (T.C., P.S.), Ghent University, Ghent, Belgium.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dirk De Bacquer
From the Department of Medicine, Perelman School of Medicine and Hospital of the University of Pennsylvania, Philadelphia (J.A.C., P.Z.); Department of Medicine, Philadelphia VA Medical Center, PA (J.A.C., P.S.-K., S.R.A., S.G.); Department of Cardiovascular Diseases, Ghent University Hospital, Ghent, Belgium (E.R.R., M.L.D.B., D.D.B.); and Department of Public Health (E.R.R.), Department of Industrial Technology and Construction (T.C.), and Institute Biomedical Technology, iMinds Future Health Department (T.C., P.S.), Ghent University, Ghent, Belgium.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott R. Akers
From the Department of Medicine, Perelman School of Medicine and Hospital of the University of Pennsylvania, Philadelphia (J.A.C., P.Z.); Department of Medicine, Philadelphia VA Medical Center, PA (J.A.C., P.S.-K., S.R.A., S.G.); Department of Cardiovascular Diseases, Ghent University Hospital, Ghent, Belgium (E.R.R., M.L.D.B., D.D.B.); and Department of Public Health (E.R.R.), Department of Industrial Technology and Construction (T.C.), and Institute Biomedical Technology, iMinds Future Health Department (T.C., P.S.), Ghent University, Ghent, Belgium.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thierry C. Gillebert
From the Department of Medicine, Perelman School of Medicine and Hospital of the University of Pennsylvania, Philadelphia (J.A.C., P.Z.); Department of Medicine, Philadelphia VA Medical Center, PA (J.A.C., P.S.-K., S.R.A., S.G.); Department of Cardiovascular Diseases, Ghent University Hospital, Ghent, Belgium (E.R.R., M.L.D.B., D.D.B.); and Department of Public Health (E.R.R.), Department of Industrial Technology and Construction (T.C.), and Institute Biomedical Technology, iMinds Future Health Department (T.C., P.S.), Ghent University, Ghent, Belgium.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick Segers
From the Department of Medicine, Perelman School of Medicine and Hospital of the University of Pennsylvania, Philadelphia (J.A.C., P.Z.); Department of Medicine, Philadelphia VA Medical Center, PA (J.A.C., P.S.-K., S.R.A., S.G.); Department of Cardiovascular Diseases, Ghent University Hospital, Ghent, Belgium (E.R.R., M.L.D.B., D.D.B.); and Department of Public Health (E.R.R.), Department of Industrial Technology and Construction (T.C.), and Institute Biomedical Technology, iMinds Future Health Department (T.C., P.S.), Ghent University, Ghent, Belgium.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Supplemental Materials
  • Info & Metrics
  • eLetters

Jump to

  • Article
    • Abstract
    • Introduction
    • Methods
    • Results
    • Discussion
    • Sources of Funding
    • Disclosures
    • Footnotes
    • References
  • Figures & Tables
  • Supplemental Materials
  • Info & Metrics
  • eLetters
Loading

Abstract

Effective arterial elastance (EA) was proposed as a lumped parameter that incorporates pulsatile and resistive afterload and is increasingly being used in clinical studies. Theoretical modeling studies suggest that EA is minimally affected by pulsatile load, but little human data are available. We assessed the relationship between EA and arterial load determined noninvasively from central pressure–flow analyses among middle-aged adults in the general population (n=2367) and a diverse clinical population of older adults (n=193). In a separate study, we investigated the sensitivity of EA to changes in pulsatile load induced by isometric exercise (n=73). The combination of systemic vascular resistance and heart rate predicted 95.6% and 97.8% of the variability in EA among middle-aged and older adults, respectively. EA demonstrated a quasi-perfect linear relationship with the ratio of systemic vascular resistance/heart period (middle-aged adults, R=0.972; older adults, R=0.99; P<0.0001). Aortic characteristic impedance, total arterial compliance, reflection magnitude, and timing accounted together for <1% of the variability in EA in either middle-aged or older adults. Despite pronounced changes in pulsatile load induced by isometric exercise, changes in EA were not independently associated with changes pulsatile load but were rather a nearly perfect linear function of the ratio of systemic vascular resistance/heart period (R=0.99; P<0.0001). Our findings demonstrate that EA is simply a function of systemic vascular resistance and heart rate and is negligibly influenced by (and insensitive to) changes in pulsatile afterload in humans. Its current interpretation as a lumped parameter of pulsatile and resistive afterload should thus be reassessed.

  • arterial load
  • characteristic impedance
  • effective arterial elastance
  • total arterial compliance
  • ventricular–arterial coupling
  • wave reflections

Introduction

Left ventricular (LV) afterload is an important determinant of normal cardiovascular function and a key pathophysiologic factor in various cardiac disease states. In the presence of a normal aortic valve, LV afterload corresponds to the mechanical load imposed by the systemic arterial tree (arterial load). Arterial load is influenced by arterial health and is a key determinant of LV systolic and diastolic function, LV remodeling, and the risk of heart disease.1–3

Accurate physiological characterization of parameters of arterial load is crucial to interpreting human data related to ventricular–arterial interactions. Arterial load can be precisely and comprehensively characterized via analyses of aortic pressure–flow relationship. Aortic input impedance analyses obtained in this manner constitute the gold standard analytic method for the assessment of arterial load.1,4–7 Pressure–flow analyses allow the quantification of steady or resistive load as well as various components of pulsatile load.1,8 Early studies of aortic input impedance were performed using invasive measurements, but more recently, comprehensive noninvasive assessments of arterial load via pressure–flow analyses have been shown to be feasible in both clinical and epidemiological settings, using a combination of arterial tonometry and Doppler echocardiography. This noninvasive approach has provided significant insights into the role of arterial hemodynamics in normal aging, sex-related physiological differences,9,10 hypertension,11 obesity,12 diabetes mellitus,13 myocardial dysfunction,14 heart failure,2,15 and the hemodynamic effects of pharmacological interventions16,17 in humans.

Motivated by the need to represent arterial load in the pressure–volume plane, the determinants of the end-systolic pressure (PES)–stroke volume (SV) relationship were assessed by Sunagawa et al.18,19 Making substantial simplifying assumptions about the arterial tree, the authors derived an equation that relates the slope of this relation to arterial properties and proposed that this slope (which they called effective arterial elastance [EA]) is a lumped parameter of aortic input impedance, which captures relevant information about both pulsatile and resistive components of afterload. Although EA is attractive because of its simplicity, there are various disadvantages of EA as an index of arterial load. EA is prominently influenced by heart rate (HR; a cardiac, rather than an arterial property)20,21 and its sensitivity to pulsatile load, as opposed to resistive load,20,21 has not been addressed properly. The latter issue has important implications, given the well-recognized importance of pulsatile LV load.1–3 Although little evidence exists on the sensitivity of EA to pulsatile load, the view that it incorporates both resistive and pulsatile load is increasingly accepted. Modeling approaches suggest that EA has little dependence on pulsatile load and depends largely on the ratio between systemic vascular resistance (SVR) and heart period (T), the latter being the inverse of HR.20 However, data in humans are scarce and limited to 2 small studies.21,22

In this study, we aimed (1) to assess the relationship between EA and indices of pulsatile and resistive arterial load obtained via central arterial pressure–flow analyses in a general population-based sample of middle-aged adults without clinically evident cardiovascular disease (substudy 1A) and in a diverse clinical population of older adults with suspected or established cardiovascular disease (substudy 1B) and (2) to assess the sensitivity of EA to detect changes in specific parameters of arterial load in response to isometric exercise, an intervention with known pronounced effects on pulsatile load23 (substudy 2).

Methods

Study Population

Substudy 1

For the assessment of the relationship between EA and specific indices of arterial load at rest, we investigated the following 2 populations:

Substudy 1A: The Asklepios study cohort, composed of 2524 men and women aged 35 to 55 years, without evidence of overt cardiovascular disease, sampled from the Belgian communities of Erpe-Mere and Nieuwerkerken, as previously described in detail.24,25 Complete echocardiographic and tonometry data for analyses of arterial load were available from 2368 subjects.

Substudy 1B: Given that pulsatile (rather than resistive) load may more prominently affect EA in older age groups or those with cardiovascular disease, we also studied a population of older adults (n=193) with established or suspected cardiovascular disease, referred for a clinically indicated cardiac MRI examination at the Philadelphia Veterans Affairs Medical Center.

Substudy 2

To assess changes in response to isometric handgrip exercise, we enrolled adults aged 20 to 80 years. Subjects were studied at the echocardiography laboratories of the Hospital of the University of Pennsylvania and Philadelphia VA Medical Center. We excluded pregnant women, subjects with a personal or family history of hypertrophic cardiomyopathy or those with poor acoustic windows.

The corresponding institutional review boards or ethical committees approved all substudies, and all subjects provided written informed consent.

Assessment of Proximal Aortic Inflow

Inflow to the proximal aorta was examined using Doppler echocardiography in all substudies, except for substudy 1B (which used MRI to measure aortic flow, as described below). Echocardiographic examinations were performed using a Vivid-7 ultrasound platform (Vingmed Ultrasound, Horten, Norway) as previously described.24,25 Instantaneous LV outflow tract velocities were measured form the apical 5-chamber view and multiplied by LV outflow tract cross-sectional area to obtain volume flow.

In substudy 1B, which enrolled patients referred for a cardiac MRI examination, we measured ascending aortic flow with phase-contrast MRI, using a 1.5-T Avanto or Espree system (Siemens Medical Solutions). A phase-contrast gradient echo pulse sequence with through-plane velocity encoding was applied during free-breathing using retrospective gating, in a plane perpendicular to the long axis of the ascending aorta at the level of the pulmonary artery bifurcation. Maximal velocity encoding was usually set at 150 cm/s but adjusted during the examination to avoid aliased velocity measurements. Other typical parameters were slice thickness 6 mm, matrix 192×192, and repetition time ≈10 ms. Images were analyzed using the freely available software Segment.26

Arterial Tonometry

Arterial tonometry was performed in the supine position, simultaneously with echocardiographic LV outflow tract interrogations or immediately after the MRI, using high-fidelity Millar applanation tonometers (SPT-301; Millar Instruments, Houston, TX) and dedicated acquisition platforms, either with a custom-made platform (Asklepios study)24,25 or using the Sphygmocor device (Atcor Medical, Sydney, Australia). Carotid pressure waveforms were calibrated with brachial diastolic and mean blood pressure; the latter was measured via numeric integration of the brachial tonometric pressure waveform in substudy 1A (Asklepios study)25 or measured with an oscillometric device (HP-78352c; Hewlett-Packard, Palo Alto, CA) in substudies 1B and 2. Carotid pressure waveforms were exported and further processed in an identical fashion in all cases, as described below.

Pressure–Flow Analyses

Pressure (P) and flow (Q) velocity recordings were processed off-line using custom-designed software written in Matlab (The Mathworks, Natick, MA) as previously described.25,27 Proximal aortic characteristic impedance (Zc) was computed in the time domain as the slope of the early systolic pressure–flow relationship.2,25 As previously described in detail,25 the pressure wave was separated into its forward (Pf) and backward (Pb) traveling component (ie, the reflected wave)1,6,25,28,29:

Embedded Image Embedded Image

Reflection magnitude was defined as the ratio of the amplitudes of Pb and Pf (Pb/Pf). Reflected wave transit-time (RWTT) was computed from wave separation analysis as the moment in time where Pb adds to Pf, as previously described.30 Total arterial compliance (TAC) was calculated via the pulse pressure method.31 Alternative analyses were performed with TAC computed by the area method.32 SVR was computed as mean aortic pressure divided by cardiac output. EA was computed as the ratio of PES (ie, pressure at the dicrotic notch) to SV.19,20,22

Handgrip Exercise (Substudy 2)

For this substudy, after acquisitions of baseline pressure and flow measurements, subjects performed 3 maximal voluntary dominant forearm contractions with a Stoelting handgrip dynamometer (Stoelting, Wood Dale, IL). The force of contraction was averaged, and a submaximal target of 40% was used for a sustained handgrip effort until fatigue. Carotid tonometry and echocardiographic assessments of LV outflow tract flow were performed immediately before termination of the handgrip maneuver and used for pressure–flow analyses, as described above.

Carotid–Femoral Pulse Wave Velocity Measurements

Because arterial load is strongly influenced by arterial stiffness, we also assessed the association between EA and carotid–femoral pulse wave velocity (PWV; a well-established index of arterial stiffness) in substudies 1A and 1B. In substudy 1A (Asklepios study population), carotid–femoral PWV was calculated using the foot-to-foot method using carotid and femoral recordings as previously described.24,25 In substudy 1B, carotid–femoral PWV was calculated using the Sphygmocor PVx device (Atcor Medical, Sydney, Australia).

Statistical Analyses

The relationship between EA and specific indices of resistive (SVR) and pulsatile load (aortic Zc, TAC, reflection magnitude, and RWTT) was analyzed using multivariable linear regression models in which EA was the dependent variable, with specific indices of arterial load and HR included as independent variables. We assessed the amount of variability in EA that is accounted for by SVR, HR, and indices of pulsatile load, by examining the R2 increase associated with the addition of all indices of pulsatile load (aortic Zc, TAC, reflection magnitude, and RWTT) to a model containing HR and SVR. Because previous modeling studies suggest that EA is a linear function of the SVR/heart period (the latter being the inverse of HR),20 we also built models in which this ratio replaced SVR and HR in the list of independent variables. For the experimental substudy, which studied the effects of isometric exercise, we used similar statistical methods to assess the amount of variability in the change in EA that is accounted for by the change in individual indices of arterial load and HR, computed in all cases by subtracting the postintervention value from the resting value. Given that for any given heart rate, EA is different from SVR only to the degree that PES is different than mean arterial pressure (MAP), we performed an alternative set of analyses assessing how pulsatile load affects the difference between PES and MAP.

Multi-colinearity of predictor variables was evaluated with variance inflation factors and condition indices and addressed with mean centering as needed. Statistical significance was defined as 2-tailed α<0.05. Statistical analyses were performed using SPSS for Mac v20 (SPSS Inc, Chicago, IL).

Results

Table 1 shows important demographic and clinical characteristics of subjects included in each substudy.

View this table:
  • View inline
  • View popup
Table 1.

Demographic, Clinical, and Hemodynamic Characteristics of Study Subjects in the Various Substudies*

Relationship Between Arterial Load and EA in Middle-Aged Adults

Table 2 shows regression models assessing the association between EA and specific indices of arterial load among middle-aged adults (Asklepios study). In this population, SVR and HR predicted 95.6% of the variability in EA. The ratio of SVR/heart period (SVR/T) was highly correlated with EA (R=0.972; R2=0.945). Table S1 in the online-only Data Supplement presents unadjusted correlations and R2 values between EA and indices of pulsatile load. Correlations between SVR and indices of pulsatile load are also presented for comparison. It can be seen that the correlations between EA and pulsatile load indices were weaker than the quasi-perfect correlation between EA and either the SVR or the SVR/T ratio. It is also apparent that the magnitude of the correlations between EA and indices of pulsatile load paralleled the magnitude of the correlations between SVR and indices of pulsatile load.

View this table:
  • View inline
  • View popup
Table 2.

Relationship Between Effective Arterial Elastance and Indices of Pulsatile Load in Middle-Aged Adults From a General Population Sample (Asklepios Study)

In a multivariate model containing SVR/T and all indices of pulsatile load as predictors of EA (Table 2), SVR/T was the strongest predictor (standardized β=0.91; P<0.0001). A lower TAC and greater reflection magnitude were both weakly associated with a greater EA. However, a longer RWTT was also associated with a higher EA. Aortic Zc was not independently associated with EA. All indices of pulsatile load combined increased the model R2 by <0.01 (ie, they independently accounted for <1% of the variability in EA, after accounting for SVR/T ratio). Adjustment for sex and exclusion of subjects taking vasoactive medications did not appreciably influence the observed associations (not shown).

Relationship Between Arterial Load and EA in Older Adults

Table 3 shows regression models assessing the association between EA and specific indices of arterial load in older adults. In this population, SVR and HR predicted 97.8% of the variability in EA, whereas the ratio SVR/T predicted 99% of the variability in EA. Unadjusted correlations between EA and pulsatile load indices were weaker and closely paralleled the magnitude of the correlations between SVR and indices of pulsatile load (Table S1).

View this table:
  • View inline
  • View popup
Table 3.

Relationship Between Effective Arterial Elastance and Indices of Pulsatile Load in Older Adults From a Diverse Clinical Sample

In a multivariate model containing SVR/T and all indices of pulsatile load as predictors of EA, SVR/T was the strongest predictor (standardized β=0.99; P<0.0001). A lower TAC and greater reflection magnitude were both weakly associated with an increase in EA. However, a lower aortic Zc and a longer RWTT (both of which indicate more favorable pulsatile loading) were also associated with a higher EA. All indices of pulsatile load increased the model R2 by 0.002 (ie, they independently accounted for only 0.2% of the variability in EA, after accounting for the SVR/T ratio). Results were similar when only subjects with a LV ejection fraction >45% were included (Table S2).

Adjustment for sex and vasoactive medications shown in Table 1 did not appreciably influence the observed associations (not shown).

Relationship Between Changes in Arterial Load and Changes in EA After Isometric Exercise

Table 4 shows changes associated with isometric exercise in substudy 2. Isometric exercise induced an increase in HR (+6.2 bpm; P<0.0001), an increase in SVR (+209 dyn·s/cm5; P<0.0001), a reduction in TAC (−0.33 mL/mm Hg; P=0.002), an increase in proximal aortic Zc (+0.027; P=0.002), an increase in reflection magnitude (+0.04; P=0.001), and a shorter RWTT (−12 ms; P<0.0001).

View this table:
  • View inline
  • View popup
Table 4.

Changes in Arterial Load in Response to Isometric Exercise

Table 5 shows regression models assessing the association between the change in EA and the change in specific indices of arterial load in response to isometric exercise. The change in SVR and HR predicted 96.8% of the variability in the change in EA. The change in the SVR/T was quasi-perfectly correlated with the change in EA (R=0.99; R2=0.978), as shown in Table 3 (model 2). Unadjusted correlations between the change in EA and the change in indices of pulsatile load were much weaker and closely paralleled the magnitude of the correlations between the change in SVR and the change in indices of pulsatile load (Table S1).

View this table:
  • View inline
  • View popup
Table 5.

Changes in SVR, Heart Rate, and Indices of Pulsatile Load as Predictors of Changes in Effective Arterial Elastance in Response to Isometric Exercise

In a multivariate model assessing the change in SVR/T and the change in all indices of pulsatile load as predictors of the change in EA in response to isometric exercise, the change in SVR/T was the strongest predictor (standardized β=0.96; P<0.0001). A reduction in TAC and an increase in reflection magnitude in response to isometric handgrip exercise were both weakly associated with an increase in EA (standardized β≤0.05 for both). The changes in all indices of pulsatile load combined accounted for an increase in the model R2 of 0.005 (ie, they independently accounted for only 0.5% of the variability in the change in EA, after accounting for the change in SVR/T).

Adjustment for sex and vasoactive medications shown in Table 1 did not appreciably influence the observed associations (not shown).

Analyses Using TAC Computed With the Area Method

Because the pulse pressure method variably underestimates arterial compliance relative to the area method, we performed additional analyses that included TAC computed with the area method (Tables S3–S5). Results from these regression models were similar to those obtained in models that used TAC computed with the pulse pressure method.

Correlations Between Pulsatile Load and the Difference Between MAP and PES

We assessed the variability in PES that is accounted for by (1) MAP, (2) the difference between PES and MAP (PES−MAP) in the study populations. Among middle-aged adults (substudy 1A), MAP and (PES−MAP) accounted for 77.6% and 12.5% of the variability in PES, respectively. In older adults (substudy 1B), MAP and (PES−MAP) accounted for 88.2% and 11.8% of the variability of PES, respectively. Similarly, in substudy 2, the MAP change in response to handgrip exercise accounted for 89.6% of the variability in PES change, whereas the change in PES−MAP accounted for only 10.4% of the variability in PES change.

The main determinant of PES−MAP was HR, rather than pulsatile load (Table S6). Furthermore, PES−MAP was not significantly related to ascending aortic Zc in any substudy; although it increased with decreasing TAC, it also increased with a greater RWTT (a favorable pattern of pulsatile load) among older adults.

All indices of pulsatile load together accounted for only 24% and 28% of the variability in PES−MAP among middle-aged adults and older adults, respectively. Similarly, in substudy 2, the change in all indices of pulsatile load together accounted for only 24% of the variability in the PES−MAP change.

In summary, pulsatile load accounted for a small proportion of the variability of PES−MAP, which in itself accounted for a small proportion of the variability in PES, because most of the latter variability was determined by MAP.

Correlation Between EA and Carotid–Femoral PWV

In regression models containing the SVR/T ratio and carotid–femoral PWV as predictors of EA, the latter did not bear any independent relationship with EA. In these analyses among middle-aged adults (substudy 1A), the standardized coefficient for SVR/T was 0.97 (P<0.0001), whereas the standardized coefficient for carotid–femoral PWV was <0.001 (P=0.95). Among older adults (substudy 1B), the standardized coefficient for SVR/T was 0.996 (P<0.0001), whereas the standardized coefficient for carotid–femoral PWV was −0.003 (P=0.66).

Discussion

We assessed the relationship between EA and specific indices of arterial load determined from central pressure–flow analyses among middle-aged adults in the general population, as well as a diverse clinical population of older adults. We also investigated the sensitivity of EA to changes in pulsatile load induced by isometric exercise. Our findings consistently demonstrate that EA is a quasi-perfect function of SVR and HR (more specifically, of SVR/T), with weak, inconsistent and in some cases, erratic contributions from measures of pulsatile load such as aortic Zc, TAC, or wave reflection magnitude and timing. Similarly, despite pronounced changes in pulsatile load induced by isometric exercise, changes in EA were a quasi-perfect linear function of the change in SVR/T and negligibly influenced by changes in pulsatile load. Our empirical findings demonstrate, in agreement with modeling studies,20 that EA depends almost entirely on SVR and HR and has poor sensitivity to the human pathophysiological ranges of pulsatile afterload observed in vivo.

The derivation of EA as a summary index of arterial load was motivated by the appeal of expressing afterload by a linear PES–SV relationship, which can be expressed in the same units as LV end-systolic elastance. However, EA does not represent the true physical arterial elastance (ie, the inverse of arterial compliance) nor does it depend purely on arterial properties. Defining arterial elastance as the ratio of PES/SV treats the arterial system as an elastic chamber in which pressure increases linearly from zero to PES as a result of the SV. However, in reality, arterial pressure pulsations hover around a nonzero mean pressure (which, in turn, depends on SVR and cardiac output). The PES/SV ratio (EA) is therefore much different from true arterial elastance and profoundly influenced by SVR. It also follows that, to the degree that PES closely approximates MAP, EA closely approximates SVR when the latter is expressed in elastance units (ie, normalized for time). This leads to the prediction that the SVR/T ratio (which depends purely on resistive load and HR, a cardiac property) is the main determinant of EA. This can be expressed as follows: SVR equals the ratio of MAP to cardiac output, and the latter is in turn equivalent to the product of SV and HR:

Embedded Image(1)

where T is the cardiac time period (the inverse of HR). Therefore, to the degree that PES is similar to MAP, SVR/T ratio is similar to the ratio of PES to SV:

Embedded Image(2)

Despite the appealing nature of EA as a single index that lumps resistive and pulsatile afterload, pulsatile load is in reality complex, time-varying, and impossible to characterize by a single number. The gold standard expression of arterial load is the aortic input impedance spectrum, which fully characterizes the mechanical load imparted by the vascular system downstream of the proximal aorta in the frequency domain. Several arterial functional indices can be derived from this impedance spectrum or from analogous analyses in the time domain.6,29,33 A basic set of parameters that characterizes arterial load includes SVR and several indices of pulsatile load,1,2,6,7,29,33 including (1) proximal aortic Zc, (2) TAC, (3) reflection magnitude, and (4) reflected wave timing. The notion that EA represents a lumped parameter of arterial load incorporating both resistive and pulsatile load originated from mathematical analyses by Sunagawa et al,19 in which the arterial system was represented by a 3-element Windkessel model consisting of aortic Zc, peripheral resistance (R), and arterial compliance (C). Important simplifying assumptions, which are usually overlooked in the literature, were undertaken in this derivation. Although when properly interpreted, the 3-element Windkessel model is an useful representation of the arterial tree, it does not explicitly account for wave conduction or reflections, thus neglecting the effects of reflected waves on LV afterload,1,3,6,34,35 myocardial hypertrophy,36–38 fibrosis,36 dysfunction,1,14,34,39–42 and the risk of heart failure.3 More importantly, the derivation by Sunagawa et al assumed a square-shaped aortic pressure waveform in systole, rising instantaneously at the beginning of systole from the end-diastolic to the PES value, being subsequently completely flat until end-systole. This marked simplification thus ignores all pulsatile pressure phenomena occurring above PES, neglecting the effects of pulsatile load on the time-resolved systolic pressure profile. As originally acknowledged by Sunagawa et al,19 a relatively large error in this model occurs when the area under the pressure curve above PES increases, which occurs precisely in situations of increased pulsatile load (such as aging and arterial stiffening).1 The nonphysiological square-shaped systolic pressure profile also neglects the variability in the slope of the early systolic pressure–flow relationship (which is governed by aortic Zc), at a time during which most of the pulse pressure is achieved and peak myocardial wall stress occurs.27 Such profound limitations of EA can also be inferred by analysis of the formula derived by Sunagawa et al (Equation S2) to express the arterial determinants of PES/SV (ie, EA), as summarized in the online-only Data supplement. Briefly, careful analysis of this derivation reveals that the effect of compliance is negligible and the effect of proximal aortic Zc is reduced to a minuscule contribution to total resistance (which originates predominantly in the microvasculature), fully ignoring the important role of Zc in the pulsatile pressure–flow relationship. Taking into account straightforward algebraic considerations, this derivation actually shows that EA closely approximates R/T.

In addition to the relatively simple analytic arguments discussed above, more complex modeling studies assessing the sensitivity of EA to SVR and pulsatile load have been performed using a mathematical heart-arterial interaction model.20 In such studies, Segers et al20 demonstrated a strong linear relationship between EA and SVR/T and showed that, within the human pathophysiologic ranges, this ratio was a much more important determinant of EA than TAC.

The concept that EA represents a lumped index of resistive and pulsatile load has gained widespread acceptance, with little in vivo data to support and despite the considerations and modeling studies mentioned above. To our knowledge, only 2 small studies assessing this issue in humans are available.21,22 Kelly et al22 studied 9 men and 1 woman referred for cardiac catheterization. They performed arterial hemodynamic measurements before and after an acute preload reduction and in 7 cases, a pharmacological intervention. The authors assessed the relationship between the PES/SV ratio and the Sunagawa expression of EA (Equation S2, discussed above). Not surprisingly, they demonstrated that this expression, which they called an input impedance measure of EA, adequately predicted the PES/SV ratio. However, in such expression, the influence of pulsatile load had already been eliminated largely because of important nonphysiological simplifying assumptions mentioned above. Interestingly, in this study, EA had an almost perfect linear relationship with SVR/T (R=0.98). However, the authors noted that EA was systematically greater than SVR/T (the relationship thus differing from the line of identity) and interpreted this to be the result of the oscillatory load caused by reduced TAC, increased Zc and wave reflections, concluding that EA better indexed the arterial load effects on the LV. Of note, although the authors derived indices of pulsatile load (aortic Zc, TAC, and wave reflections) from aortic input impedance spectra, they did not actually present relationships between these measures and EA. Importantly, the quasi-perfect relationship between EA and SVR/T was obtained using values of EA and SVR/T from all measurements derived from their 10 study subjects at baseline and after various interventions. Not only was pulsatile load different between individuals at baseline, but markedly varied between measurements (TAC, for instance, increased by 75.6% after preload reduction and aortic Zc decreased by 44%, compared with baseline). Given that pulsatile load was highly variable, had it influenced EA to any significant degree, it would have distorted the otherwise perfect relationship between SVR/T and EA, rather than simply shift it from the line of identity, while maintaining its high coefficient of correlation. If one accepts that EA truly integrates pulsatile load, shifting the SVR/T–EA relationship from the line of identify while maintaining its nearly perfect correlation coefficient would imply that all these measurements were obtained under identical pulsatile load conditions (such that all points were shifted up by the same amount, thus preserving the high correlation), which was clearly not the case. The systematic difference between EA and SVR/T thus cannot be interpreted as support of the sensitivity of the former to pulsatile load. Careful analysis of the study data indeed shows that the responsible factor for most of this difference was the use of LV pressure at the time of peak LV elastance, rather than actual end-systolic arterial pressure (dicrotic notch pressure), to compute EA. Notably, LV pressure at the time of peak LV elastance was 15 mm Hg greater than actual arterial PES, leading to a systematic overestimation of EA relative to SVR/T, because EA is greater than SVR/T only to the degree that PES is greater than MAP.

In the only other study assessing the relationship between EA and pulsatile load in humans, Chemla et al21 studied 66 subjects and demonstrated some sensitivity of EA to TAC. However, in this study, TAC was estimated as SV/pulse pressure, which is affected by not only TAC but also SVR. Furthermore, the influence of other parameters of pulsatile load was not assessed. Our study addressed the influence of various indices of pulsatile load in middle-aged adults without established cardiovascular disease, as well as a clinical population of older individuals, thus encompassing a wide range of pathophysiologic values of pulsatile load. In addition, we assessed changes in EA and various arterial parameters in response to an experimental intervention that induced pronounced effects on pulsatile arterial load. Despite marked changes in Zc, TAC, reflection magnitude, and timing in response to handgrip exercise, EA changed in a quasi-perfect linear fashion with the SVR/T ratio, indicating that EA is insensitive to, and does not adequately integrate, changes in pulsatile arterial load.

In addition to the direct computation of EA based on a known value of PES, indirect approximations have been proposed when PES is unknown, such as assuming that PES equals 90% of systolic blood pressure43 or directly approximating EA using the following formula: (2×systolic blood pressure+diastolic blood pressure)/3 SV.22 To the degree that a directly measured EA is an inadequate index to assess pulsatile load, any approximations will be similarly inadequate.

Our findings have implications for the interpretation of clinical studies addressing the relationship between arterial load and disease states or cardiac dysfunction. Weber et al44 demonstrated that EA was less useful than central pulse pressure or reflected wave amplitude to discriminate patients with heart failure with preserved ejection fraction from patients with other causes of exertional dyspnea. Similarly, among adults without established cardiovascular disease, measures of pulsatile load were more strongly related to diastolic mitral annular tissue velocities than EA. Only specific measures of pulsatile load (such as aortic Zc and measures of wave reflections) independently predicted mitral annular velocities in that study.14 Furthermore, in a recent prospective study among patients with established heart failure and preserved ejection fraction, EA failed to predict adverse outcomes.45

Because EA is used along with end-systolic LV elastance as an index of ventricular–arterial coupling, our findings imply that this paradigm does not properly assess the effects of pulsatile load on the heart. The pressure–volume paradigm characterizes only limited aspects of ventricular–arterial coupling (such as energetic efficiency and SV changes), which is a much broader concept. Indeed, although as shown here, pulsatile load does not significantly affect the PES/SV relationship (and thus the EA/EES ratio), pulsatile load is clearly important because of its effects on LV fibrosis, dysfunction, and failure. The LV loading sequence, in particular, which is intrinsically neglected by the pressure–volume paradigm, is an important determinant of maladaptive remodeling, hypertrophy, diastolic dysfunction, and heart failure risk.1,34,36,37,40,46,47

Our study should be interpreted in the context of its strengths and limitations. Strengths include the large sample size and the high degree of consistency in our findings across different substudies, as well as the assessment of resting arterial load indices and changes in response to a suitable intervention. For obvious practical and safety reasons, we performed noninvasive measurements rather than invasive measurements of central pressure. However, the same pressure signals were used to compute EA and all parameters of pulsatile load; therefore, any measurement bias would have affected EA and its determinants in parallel, thus not affecting our conclusions. In addition, the main advocated use of EA is its simplicity for use as a noninvasive parameter of arterial load; accordingly, comprehensive assessments of pulsatile load were obtained from noninvasive measurements, which avoids potential advantages of invasively assessed pressure–flow relationships over noninvasively assessed EA.

Perspectives

Assessment of arterial load and ventricular–vascular coupling provides important physiological information and is increasingly used in clinical and epidemiological human research. Our study demonstrates that EA, which has been interpreted as an index of integrated resistive and pulsatile arterial load, is insensitive to the latter and dependent almost entirely on the former, as well as on HR. Its current interpretation as a lumped parameter of pulsatile and resistive afterload should thus be reassessed. Comprehensive pressure–flow analyses provide a powerful alternative for the noninvasive assessment of arterial load.

Sources of Funding

This research was funded by Fonds voor Wetenschappelijk Onderzoek Vlaanderen research grants G.0427.03 and FWO G.0838.10 (for the Asklepios Study) and 1R21AG043802-01 (J.A. Chirinos).

Disclosures

None.

Footnotes

  • The online-only Data Supplement is available with this article at http://hyper.ahajournals.org/lookup/suppl/doi:10.1161/HYPERTENSIONAHA.114.03696/-/DC1.

  • Received May 12, 2014.
  • Revision received May 27, 2014.
  • Accepted July 8, 2014.
  • © 2014 American Heart Association, Inc.

References

  1. 1.↵
    1. Nichols W,
    2. O’Rourke M,
    3. Vlachopolous C
    Mcdonald’s Blood Flow in Arteries. Theoretical, Experimental and Clinical Principles. London: Hodder Arnold; 2011.
  2. 2.↵
    1. Mitchell GF,
    2. Tardif JC,
    3. Arnold JM,
    4. Marchiori G,
    5. O’Brien TX,
    6. Dunlap ME,
    7. Pfeffer MA
    . Pulsatile hemodynamics in congestive heart failure. Hypertension. 2001;38:1433–1439.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Chirinos JA,
    2. Kips JG,
    3. Jacobs DR Jr.,
    4. Brumback L,
    5. Duprez DA,
    6. Kronmal R,
    7. Bluemke DA,
    8. Townsend RR,
    9. Vermeersch S,
    10. Segers P
    . Arterial wave reflections and incident cardiovascular events and heart failure: MESA (Multiethnic Study of Atherosclerosis). J Am Coll Cardiol. 2012;60:2170–2177.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Milnor WR
    . Arterial impedance as ventricular afterload. Circ Res. 1975;36:565–570.
    OpenUrlFREE Full Text
  5. 5.↵
    1. Murgo JP,
    2. Westerhof N,
    3. Giolma JP,
    4. Altobelli SA
    . Aortic input impedance in normal man: relationship to pressure wave forms. Circulation. 1980;62:105–116.
    OpenUrlFREE Full Text
  6. 6.↵
    1. Chirinos JA,
    2. Segers P
    . Noninvasive evaluation of left ventricular afterload: part 2: arterial pressure-flow and pressure-volume relations in humans. Hypertension. 2010;56:563–570.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. O’Rourke MF
    . Vascular impedance in studies of arterial and cardiac function. Physiol Rev. 1982;62:570–623.
    OpenUrlFREE Full Text
  8. 8.↵
    1. Ooi H,
    2. Chung W,
    3. Biolo A
    . Arterial stiffness and vascular load in heart failure. Congest Heart Fail. 2008;14:31–36.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Chirinos JA,
    2. Segers P,
    3. Gillebert TC,
    4. Gupta AK,
    5. De Buyzere ML,
    6. De Bacquer D,
    7. St John-Sutton M,
    8. Rietzschel ER
    ; Asklepios Investigators. Arterial properties as determinants of time-varying myocardial stress in humans. Hypertension. 2012;60:64–70.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Coutinho T,
    2. Borlaug BA,
    3. Pellikka PA,
    4. Turner ST,
    5. Kullo IJ
    . Sex differences in arterial stiffness and ventricular-arterial interactions. J Am Coll Cardiol. 2013;61:96–103.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Mitchell GF,
    2. Lacourcière Y,
    3. Ouellet JP,
    4. Izzo JL Jr.,
    5. Neutel J,
    6. Kerwin LJ,
    7. Block AJ,
    8. Pfeffer MA
    . Determinants of elevated pulse pressure in middle-aged and older subjects with uncomplicated systolic hypertension: the role of proximal aortic diameter and the aortic pressure-flow relationship. Circulation. 2003;108:1592–1598.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Chirinos JA,
    2. Rietzschel ER,
    3. De Buyzere ML,
    4. De Bacquer D,
    5. Gillebert TC,
    6. Gupta AK,
    7. Segers P
    ; Asklepios Investigators. Arterial load and ventricular-arterial coupling: physiologic relations with body size and effect of obesity. Hypertension. 2009;54:558–566.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Sweitzer NK,
    2. Shenoy M,
    3. Stein JH,
    4. Keles S,
    5. Palta M,
    6. LeCaire T,
    7. Mitchell GF
    . Increases in central aortic impedance precede alterations in arterial stiffness measures in type 1 diabetes. Diabetes Care. 2007;30:2886–2891.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Borlaug BA,
    2. Melenovsky V,
    3. Redfield MM,
    4. Kessler K,
    5. Chang HJ,
    6. Abraham TP,
    7. Kass DA
    . Impact of arterial load and loading sequence on left ventricular tissue velocities in humans. J Am Coll Cardiol. 2007;50:1570–1577.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Desai AS,
    2. Mitchell GF,
    3. Fang JC,
    4. Creager MA
    . Central aortic stiffness is increased in patients with heart failure and preserved ejection fraction. J Card Fail. 2009;15:658–664.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Mitchell GF,
    2. Dunlap ME,
    3. Warnica W,
    4. Ducharme A,
    5. Arnold JM,
    6. Tardif JC,
    7. Solomon SD,
    8. Domanski MJ,
    9. Jablonski KA,
    10. Rice MM,
    11. Pfeffer MA
    ; Prevention of Events With Angiotensin-Converting Enzyme Inhibition Investigators. Long-term trandolapril treatment is associated with reduced aortic stiffness: the prevention of events with angiotensin-converting enzyme inhibition hemodynamic substudy. Hypertension. 2007;49:1271–1277.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Mitchell GF,
    2. Lacourcière Y,
    3. Arnold JM,
    4. Dunlap ME,
    5. Conlin PR,
    6. Izzo JL Jr.
    . Changes in aortic stiffness and augmentation index after acute converting enzyme or vasopeptidase inhibition. Hypertension. 2005;46:1111–1117.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Sunagawa K,
    2. Maughan WL,
    3. Sagawa K
    . Optimal arterial resistance for the maximal stroke work studied in isolated canine left ventricle. Circ Res. 1985;56:586–595.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. Sunagawa K,
    2. Maughan WL,
    3. Burkhoff D,
    4. Sagawa K
    . Left ventricular interaction with arterial load studied in isolated canine ventricle. Am J Physiol. 1983;245(5 Pt 1):H773–H780.
    OpenUrl
  20. 20.↵
    1. Segers P,
    2. Stergiopulos N,
    3. Westerhof N
    . Relation of effective arterial elastance to arterial system properties. Am J Physiol Heart Circ Physiol. 2002;282:H1041–H1046.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Chemla D,
    2. Antony I,
    3. Lecarpentier Y,
    4. Nitenberg A
    . Contribution of systemic vascular resistance and total arterial compliance to effective arterial elastance in humans. Am J Physiol Heart Circ Physiol. 2003;285:H614–H620.
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Kelly RP,
    2. Ting CT,
    3. Yang TM,
    4. Liu CP,
    5. Maughan WL,
    6. Chang MS,
    7. Kass DA
    . Effective arterial elastance as index of arterial vascular load in humans. Circulation. 1992;86:513–521.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Chirinos JA,
    2. Segers P,
    3. Raina A,
    4. Saif H,
    5. Swillens A,
    6. Gupta AK,
    7. Townsend R,
    8. Emmi AG Jr.,
    9. Kirkpatrick JN,
    10. Keane MG,
    11. Ferrari VA,
    12. Wiegers SE,
    13. St John Sutton MG
    . Arterial pulsatile hemodynamic load induced by isometric exercise strongly predicts left ventricular mass in hypertension. Am J Physiol Heart Circ Physiol. 2010;298:H320–H330.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    1. Rietzschel ER,
    2. De Buyzere ML,
    3. Bekaert S,
    4. Segers P,
    5. De Bacquer D,
    6. Cooman L,
    7. Van Damme P,
    8. Cassiman P,
    9. Langlois M,
    10. van Oostveldt P,
    11. Verdonck P,
    12. De Backer G,
    13. Gillebert TC
    ; Asklepios Investigators. Rationale, design, methods and baseline characteristics of the Asklepios Study. Eur J Cardiovasc Prev Rehabil. 2007;14:179–191.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Segers P,
    2. Rietzschel ER,
    3. De Buyzere ML,
    4. Vermeersch SJ,
    5. De Bacquer D,
    6. Van Bortel LM,
    7. De Backer G,
    8. Gillebert TC,
    9. Verdonck PR
    ; Asklepios Investigators. Noninvasive (input) impedance, pulse wave velocity, and wave reflection in healthy middle-aged men and women. Hypertension. 2007;49:1248–1255.
    OpenUrlAbstract/FREE Full Text
  26. 26.↵
    1. Heiberg E,
    2. Sjögren J,
    3. Ugander M,
    4. Carlsson M,
    5. Engblom H,
    6. Arheden H
    . Design and validation of Segment–freely available software for cardiovascular image analysis. BMC Med Imaging. 2010;10:1.
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. Chirinos JA,
    2. Segers P,
    3. Gupta AK,
    4. Swillens A,
    5. Rietzschel ER,
    6. De Buyzere ML,
    7. Kirkpatrick JN,
    8. Gillebert TC,
    9. Wang Y,
    10. Keane MG,
    11. Townsend R,
    12. Ferrari VA,
    13. Wiegers SE,
    14. St John Sutton M
    . Time-varying myocardial stress and systolic pressure-stress relationship: role in myocardial-arterial coupling in hypertension. Circulation. 2009;119:2798–2807.
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    1. Westerhof N,
    2. Sipkema P,
    3. van den Bos GC,
    4. Elzinga G
    . Forward and backward waves in the arterial system. Cardiovasc Res. 1972;6:648–656.
    OpenUrlAbstract/FREE Full Text
  29. 29.↵
    1. Chirinos JA,
    2. Segers P
    . Noninvasive evaluation of left ventricular afterload: part 1: pressure and flow measurements and basic principles of wave conduction and reflection. Hypertension. 2010;56:555–562.
    OpenUrlAbstract/FREE Full Text
  30. 30.↵
    1. Segers P,
    2. Rietzschel ER,
    3. De Buyzere ML,
    4. De Bacquer D,
    5. Van Bortel LM,
    6. De Backer G,
    7. Gillebert TC,
    8. Verdonck PR
    . Assessment of pressure wave reflection: getting the timing right! Physiol Meas. 2007;28:1045–1056.
    OpenUrlCrossRefPubMed
  31. 31.↵
    1. Stergiopulos N,
    2. Meister JJ,
    3. Westerhof N
    . Evaluation of methods for estimation of total arterial compliance. Am J Physiol. 1995;268(4 Pt 2):H1540–H1548.
    OpenUrl
  32. 32.↵
    1. Liu Z,
    2. Brin KP,
    3. Yin FC
    . Estimation of total arterial compliance: an improved method and evaluation of current methods. Am J Physiol. 1986;251(3 Pt 2):H588–H600.
    OpenUrl
  33. 33.↵
    1. Mitchell GF
    . Clinical achievements of impedance analysis. Med Biol Eng Comput. 2009;47:153–163.
    OpenUrlCrossRefPubMed
  34. 34.↵
    1. Weber T,
    2. O’Rourke MF,
    3. Ammer M,
    4. Kvas E,
    5. Punzengruber C,
    6. Eber B
    . Arterial stiffness and arterial wave reflections are associated with systolic and diastolic function in patients with normal ejection fraction. Am J Hypertens. 2008;21:1194–1202.
    OpenUrlAbstract/FREE Full Text
  35. 35.↵
    1. Nichols WW,
    2. Denardo SJ,
    3. Wilkinson IB,
    4. McEniery CM,
    5. Cockcroft J,
    6. O’Rourke MF
    . Effects of arterial stiffness, pulse wave velocity, and wave reflections on the central aortic pressure waveform. J Clin Hypertens (Greenwich). 2008;10:295–303.
    OpenUrlCrossRefPubMed
  36. 36.↵
    1. Kobayashi S,
    2. Yano M,
    3. Kohno M,
    4. Obayashi M,
    5. Hisamatsu Y,
    6. Ryoke T,
    7. Ohkusa T,
    8. Yamakawa K,
    9. Matsuzaki M
    . Influence of aortic impedance on the development of pressure-overload left ventricular hypertrophy in rats. Circulation. 1996;94:3362–3368.
    OpenUrlAbstract/FREE Full Text
  37. 37.↵
    1. Hashimoto J,
    2. Westerhof BE,
    3. Westerhof N,
    4. Imai Y,
    5. O’Rourke MF
    . Different role of wave reflection magnitude and timing on left ventricular mass reduction during antihypertensive treatment. J Hypertens. 2008;26:1017–1024.
    OpenUrlCrossRefPubMed
  38. 38.↵
    1. Westerhof N,
    2. O’Rourke MF
    . Haemodynamic basis for the development of left ventricular failure in systolic hypertension and for its logical therapy. J Hypertens. 1995;13:943–952.
    OpenUrlCrossRefPubMed
  39. 39.↵
    1. Fujimoto N,
    2. Onishi K,
    3. Tanabe M,
    4. Dohi K,
    5. Funabiki K,
    6. Kurita T,
    7. Yamanaka T,
    8. Nakajima K,
    9. Ito M,
    10. Nobori T,
    11. Nakano T
    . Nitroglycerin improves left ventricular relaxation by changing systolic loading sequence in patients with excessive arterial load. J Cardiovasc Pharmacol. 2005;45:211–216.
    OpenUrlCrossRefPubMed
  40. 40.↵
    1. Gillebert TC,
    2. Lew WY
    . Influence of systolic pressure profile on rate of left ventricular pressure fall. Am J Physiol. 1991;261(3 Pt 2):H805–H813.
    OpenUrl
  41. 41.↵
    1. Kohno F,
    2. Kumada T,
    3. Kambayashi M,
    4. Hayashida W,
    5. Ishikawa N,
    6. Sasayama S
    . Change in aortic end-systolic pressure by alterations in loading sequence and its relation to left ventricular isovolumic relaxation. Circulation. 1996;93:2080–2087.
    OpenUrlAbstract/FREE Full Text
  42. 42.↵
    1. Hori M,
    2. Inoue M,
    3. Kitakaze M,
    4. Kitabatake A,
    5. Abe H
    . Altered loading sequence as an underlying mechanism of afterload dependency of ventricular relaxation in hearts in situ. Jpn Circ J. 1985;49:245–254.
    OpenUrlCrossRefPubMed
  43. 43.↵
    1. Chen CH,
    2. Fetics B,
    3. Nevo E,
    4. Rochitte CE,
    5. Chiou KR,
    6. Ding PA,
    7. Kawaguchi M,
    8. Kass DA
    . Noninvasive single-beat determination of left ventricular end-systolic elastance in humans. J Am Coll Cardiol. 2001;38:2028–2034.
    OpenUrlCrossRefPubMed
  44. 44.↵
    1. Weber T,
    2. Wassertheurer S,
    3. O’Rourke MF,
    4. Haiden A,
    5. Zweiker R,
    6. Rammer M,
    7. Hametner B,
    8. Eber B
    . Pulsatile hemodynamics in patients with exertional dyspnea: potentially of value in the diagnostic evaluation of suspected heart failure with preserved ejection fraction. J Am Coll Cardiol. 2013;61:1874–1883.
    OpenUrlCrossRefPubMed
  45. 45.↵
    1. Burke MA,
    2. Katz DH,
    3. Beussink L,
    4. Selvaraj S,
    5. Gupta DK,
    6. Fox J,
    7. Chakrabarti S,
    8. Sauer AJ,
    9. Rich JD,
    10. Freed BH,
    11. Shah SJ
    . Prognostic importance of pathophysiologic markers in patients with heart failure and preserved ejection fraction. Circ Heart Fail. 2014;7:288–299.
    OpenUrlAbstract/FREE Full Text
  46. 46.↵
    1. Fukuta H,
    2. Ohte N,
    3. Wakami K,
    4. Asada K,
    5. Goto T,
    6. Mukai S,
    7. Tani T,
    8. Kimura G
    . Impact of arterial load on left ventricular diastolic function in patients undergoing cardiac catheterization for coronary artery disease. Circ J. 2010;74:1900–1905.
    OpenUrlCrossRefPubMed
  47. 47.↵
    1. Chirinos JA,
    2. Segers P,
    3. Rietzschel ER,
    4. De Buyzere ML,
    5. Raja MW,
    6. Claessens T,
    7. De Bacquer D,
    8. St John Sutton M,
    9. Gillebert TC
    ; Asklepios Investigators. Early and late systolic wall stress differentially relate to myocardial contraction and relaxation in middle-aged adults: the Asklepios study. Hypertension. 2013;61:296–303.
    OpenUrlAbstract/FREE Full Text

Novelty and Significance

What Is New?

  • We characterized the influence of specific arterial properties on effective arterial elastance, currently regarded as a lumped parameter that incorporates pulsatile and resistive afterload.

  • We demonstrate that effective arterial elastance is merely a function of systemic vascular resistance and heart rate and is negligibly influenced by (and insensitive to) changes in pulsatile afterload in humans.

What Is Relevant?

  • Arterial load is an important determinant of normal cardiovascular function and a key pathophysiologic factor in various cardiac disease states.

  • Accurate physiological characterization of parameters of arterial load is therefore crucial to interpreting human data related to ventricular–arterial interactions.

  • Pulsatile arterial load can be precisely and comprehensively characterized via analyses of aortic pressure–flow relationships.

  • Effective arterial elastance, in contrast, depends almost entirely on systemic vascular resistance and heart rate and has poor sensitivity to the human pathophysiological ranges of pulsatile afterload observed in vivo.

Summary

Effective arterial elastance is merely a function of systemic vascular resistance and heart rate and is negligibly influenced by (and insensitive to) changes in pulsatile afterload in humans. Its current interpretation as a lumped parameter of pulsatile and resistive afterload should thus be reassessed.

View Abstract
Back to top
Previous ArticleNext Article

This Issue

Hypertension
November 2014, Volume 64, Issue 5
  • Table of Contents
Previous ArticleNext Article

Jump to

  • Article
    • Abstract
    • Introduction
    • Methods
    • Results
    • Discussion
    • Sources of Funding
    • Disclosures
    • Footnotes
    • References
  • Figures & Tables
  • Supplemental Materials
  • Info & Metrics
  • eLetters

Article Tools

  • Print
  • Citation Tools
    Effective Arterial Elastance Is Insensitive to Pulsatile Arterial LoadNovelty and Significance
    Julio A. Chirinos, Ernst R. Rietzschel, Prithvi Shiva-Kumar, Marc L. De Buyzere, Payman Zamani, Tom Claessens, Salvatore Geraci, Prasad Konda, Dirk De Bacquer, Scott R. Akers, Thierry C. Gillebert and Patrick Segers
    Hypertension. 2014;64:1022-1031, originally published July 28, 2014
    https://doi.org/10.1161/HYPERTENSIONAHA.114.03696

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Hypertension.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Effective Arterial Elastance Is Insensitive to Pulsatile Arterial LoadNovelty and Significance
    (Your Name) has sent you a message from Hypertension
    (Your Name) thought you would like to see the Hypertension web site.
  • Share on Social Media
    Effective Arterial Elastance Is Insensitive to Pulsatile Arterial LoadNovelty and Significance
    Julio A. Chirinos, Ernst R. Rietzschel, Prithvi Shiva-Kumar, Marc L. De Buyzere, Payman Zamani, Tom Claessens, Salvatore Geraci, Prasad Konda, Dirk De Bacquer, Scott R. Akers, Thierry C. Gillebert and Patrick Segers
    Hypertension. 2014;64:1022-1031, originally published July 28, 2014
    https://doi.org/10.1161/HYPERTENSIONAHA.114.03696
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Subjects

  • Basic, Translational, and Clinical Research
    • Basic Science Research

Hypertension

  • About Hypertension
  • Instructions for Authors
  • AHA CME
  • Guidelines and Statements
  • Permissions
  • Journal Policies
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
7272 Greenville Ave.
Dallas, TX 75231
email: hypertension@heart.org

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured